BIO-B vs ILMN
Bio-Rad Laboratories, Inc. Class B Common Stock · Illumina, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | BIO-B | ILMN |
|---|---|---|
| Price | $337.00 | $203.01 |
| Market Cap | $9.32B | $30.72B |
| P/E | 12.27 | 36.14 |
| P/B | 1.36 | 11.48 |
| P/S | 3.61 | 7.07 |
| ROE | 11.1% | 31.8% |
| Net Margin | 29.4% | 19.6% |
| Gross Margin | 51.9% | 66.1% |
| Revenue Growth | 0.7% | -0.7% |
| Dividend Yield | — | — |
| EPS | $27.46 | $5.62 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.